Pharmascience Sleeping Like A Baby After Sublinox Patent Win

On December 9, 2016 Justice Manson released his Public Judgement and Reasons dismissing Meda’s application for a prohibition order regarding Pharmascience’s zolpidem product and Canadian Patent No. 2,629,988. Zolpidem is used for the treatment of insomnia and is marketed under the trade name SUBLINOX. The 988 Patent is generally directed to pharmaceutical compositions of zolpidem comprising ordered mixtures...
Read More

Apotex’ Remedial Claims Based On Pfizer’s Viagra Patent Survive Another Attack

On November 18, 2016, Justice Nordheimer of the Ontario Superior Court of Justice dismissed Pfizer’s motion for leave to appeal a decision that dismissed, with two exceptions, Pfizer’s motion to strike various remedial claims made by Apotex (see our prior blog post here). Pfizer successfully asserted a patent covering sildenafil against Apotex under the PM(NOC)...
Read More

API Fails To Remove Excalibre: API’s Torque Anchor Patents Invalid Or Not Infringed

Excalibre Oil Tools Ltd. v. Advantage Products Inc. concerns the validity and infringement of three Canadian patents. Justice Manson held that the three patents (Nos. 2,264,467, 2,373,734 and 2,386,026) asserted by API were either invalid or not infringed by Excalibre’s product. The technology at issue relates to torque anchors for oil pumps. Sufficient pressure is...
Read More

Infringement To The Omax: Default Judgement In Real Estate Trade-mark Action

In Maxwell Realty Inc. v. Omax Realty Ltd., Justice McDonald considered an ex-parte motion for default judgement for trade-mark infringement. Maxwell operates a real estate agency in the provinces of Alberta and British Columbia. In 1999, Maxwell registered the the following design in association with the operation of a real estate agency: In 2015, Maxwell...
Read More

A Quick Proceeding for Quick Couplers – Summary Trial Finding of Patent Non-infringement

On October 6, 2016, Justice Southcott dismissed Cascade’s patent infringement action against Kinshofer in a motion for summary trial. Kinshofer did not contest the validity of the 065 Patent but asserted a defence of non-infringement. Background The 065 Patent is directed to safety locking devices for quick couplers used with machines, like excavators, for quickly...
Read More

Putting Your (Other) Best Foot Forward: Party May Introduce New Evidence or Argument in Subsequent Infringement Action

On September 19, 2016, Prothonotary Tabib granted, in part, Apotex’ motion to amend its statement of defence and counterclaim in an infringement action concerning Apotex’ Apo-Travoprost Z product. Apotex moved to add an allegation of anticipation, a defence of ex turpi causa based on anti-competitive conduct and two defences based on issue estoppel, abuse of...
Read More

New Evidence Of License Agreement Unable To Secure ASIA MILES Trade-mark Registrations

On October 12, 2016, Justice Southcott issued his Judgment and Reasons and Cathay Pacific Airways Limited v. Air Miles International Trading B.V., 2016 FC 1125. Background The case originated from a Trade-marks Opposition Board decision refusing five of Cathay’s ASIA MILES trade-mark applications (1,271,320, 1,271,440, 1,271,441, 1,276,725 and 1,276,720) for registration in association with the operation...
Read More

Qualifying Read-Ins Must Be “Reasonably Connected”

In Excalibre Oil Tools Ltd. v. Advantage Products Inc., API sought an order pursuant to Rule 289 of the Federal Courts Rules ordering that Excalibre include, as part of their read-ins, additional portions of the transcripts from the examination for discovery of API on the basis that these qualifying read-ins provide clarity, context and value to...
Read More

Trial Judges Entitled To Some “Leeway” On Construction

On September 6, 2016, the Court of Appeal dismissed Nova Chemicals Corporations appeal from a judgment finding its SURPASS product infringes Canadian Patent No. 2,160,705 directed generally to polyethylene film products, such as plastic garbage bags and food wrapping. The 705 Patent was previously held valid and infringed Justice O’Keefe (see here). On appeal, Nova...
Read More

Mövenpick’s “Marché & Wave” Trade-mark Withstands Richtree’s Opposition Appeal

On September 15, 2016, Justice Boswell dismissed Richtree’s appeal, pursuant to section 56 of the Trade-marks Act, from the decision of the Trade-marks Opposition Board that had rejected Richtree’s opposition to a trade-mark application filed by Mövenpick. In 2005 Richtree purchased the assets of Richtree Markets Inc. after it became insolvent. Prior to its insolvency,...
Read More

Court Refuses to Reconsider Prohibition Order Granted On The Basis of NOA Insufficiency

As previously described here, Justice Brown granted a prohibition application brought by Bayer relating to the drug moxifloxacin hydrochloride and Canadian Patent No. 2,192,418 on the basis of NOA insufficiency notwithstanding also finding that Bayer had not established Fresenius’ allegation of non-infringement was not justified. Fresenius, in addition to appealing the Order of Justice Brown,...
Read More

On to the next round: Some of Apotex’s claims for being kept off the sildenafil market survive motion to strike

In Apotex Inc. v. Pfizer Ireland Pharmaceuticals et al., 2016 ONSC 4966, Pfizer was looking to strike out claims brought against it by Apotex under the PM(NOC) Regulations and the Trade-marks Act, as well as claims for unjust enrichment, nuisance, contrary to the principle in Ashby v. White (1703), 2 Raym. Ld. 938 and conspiracy....
Read More

Code Words Result In NOA Insufficiency

In Bayer Inc. v. Fresenius Kabi Canada Ltd., Justice Brown of the Federal Court granted Bayer’s prohibition application relating to the drug moxifloxacin hydrochloride and Canadian Patent No. 2,192,418. The 418 Patent is listed on the Patent Register against Bayer’s AVELOX I.V. solution. The 418 Patent claims a monohydrate form of moxifloxacin hydrochloride characterized by certain...
Read More

AstraZeneca’s Attempt to Vary Judgment Based on Subsequent Finding of Infringment Rejected

In 2012, Justice Hughes held that Apotex was entitled to section 8 damages by reason of AstraZeneca’s unsuccessful prohibition application in respect of Apo-omeprazole and AstraZeneca’s 762 Patent and referred the quantum of Apotex’ damages to a reference. In his reasons accompanying the 2012 Judgment, Justice Hughes held that Apotex’ possible infringement of a different AstraZeneca Patent, the...
Read More

Dude, That’s Not Your Code: Claim for Computer Authorship Denied

In Andrews v McHale, 2016 FC 624, Justice Southcott dismissed an application for declaratory relief and damages for alleged copyright infringement and infringement of moral rights relating to software systems. The dispositive issue in the case was authorship. Justice Southcott considered case law from the UK and USA but cautioned against its use, instead relying...
Read More

Hey Trademark Infringer You’re No Friend of Mine – Mister Transmission obtains injunction against Master Transmission

Responsive Brands operates throughout Canada as “Mister Transmission”. Responsive Brands is the owner of Canadian Trademark 239,868 for MISTER TRANSMISSION registered in association with transmission services for vehicles. 2248003 Ontario has operated in Orillia, Ontario under the trade name “Master Transmission & Driveline” since June 2010, when its principals left a Mister Transmission store to...
Read More